IL-37 counteracts inflammatory injury in the temporomandibular joint via the intracellular pathway.

Front Pharmacol · 2023 · PMC10694265 · PMID 38053836

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an elevated trendno p-value reported

Although Mat-IL-37 also showed an elevated trend in the cytoplasm, the most significant elevation occurred at 6–12 h and started to decrease after 12 h ( Figure 3A ).

also in 136 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.